Fig. 2From: Neoantigen vaccine: an emerging tumor immunotherapyMajor types of neoantigen vaccine. In vivo, neoantigens are eventually presented to CD4+ T cells and CD8+ T cells to induce specific immune responses and achieve anti-tumor effectsBack to article page